CT contrast medium for detecting thrombus, comprising fibrin-targeted peptide sequence-conjugated glycol chitosan-gold nanoparticles
US9717807B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 13, 2013 |
| Grant date | Aug 1, 2017 |
| Priority date | — |
| Expiry date | Mar 15, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG06T11/003
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a CT contrast agent for detecting a thrombus, comprising fibrin-targeted peptide sequence-conjugated glycol chitosan-gold nanoparticles. The CT contrast agent for detecting a thrombus according to an embodiment of the present invention may allow rapid and repeated acquisition of CT image information related to the size and location of a thrombus in cardio-cerebral vascular thrombosis, and also enables the imaging monitoring of cerebral thrombus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.